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Fresh peripheral blood mononuclear cells (PBM) isolated from healthy human donors 
and activated with concanavalin A (Con A) induced suppression of the proliferation 
response to Con A in an allogeneic mixed leukocyte culture reaction (MLC). When PBM 
were incubated in media alone for 24 hr prior to Con A activation of suppressor cells 
there was a significant decrease in the suppressive response. PBM incubated in the 
presence of thymosin for 24 hr prior to Con A activation of the suppressor cells promoted 
a further augmentation of mitogen-induced proliferation. When PBM were incubated 
with thymosin in the absence of Con A activation of suppressor cells, enhancement of 
proliferation was observed in the MLC. These experiments suggest that thymosin- 
treated PBM from healthy donors promote a helper rather than suppressive effect on 
mitogen-induced proliferation of allogeneic responder lymphocytes. 
INTRODUCTION 
Thymosin fraction 5, a polypeptide extract of calf thymus, can induce differ- 
entiation of human thymus-dependent (T) lymphocytes (1- 3). In addition, thymo- 
sin has been shown to modulate the functional capacity of differentiated T cells 
which influence immunoregulatory control over T-T and T-B lymphocyte in- 
teractions (4-6). There is evidence to suggest that thymosin can modulate NK cell 
activity and decrease spontaneous cell-mediated cytotoxicity (7). 
Thymosin is composed of at least 16 polypeptides with differing biological ac- 
tivities that can act individually, sequentially, or in concert on both pre-T and 
T-cell populations (3). A number of these peptides have been purified to homoge- 
neity and characterized chemically with sequence analysis. Several isolated pep- 
tides have been shown, in vitro, to induce either a helper effect (thymosin aJ or a 
suppressor effect (thymosin a,) (8). 
Since thymosin fraction 5 contains polypeptides which can, at the same time, 
influence helper or suppressor activity, the present studies were undertaken to 
assess thymosin effect on both helper and suppressor activity of peripheral blood 
lymphocytes from healthy human adults. 
MATERIALS AND METHODS 
Separation of peripheral blood mononuclear cells (PBM). Peripheral venous 
blood from 35 healthy laboratory and medical personnel (27 males, 8 females: ages 
21-60 years, 34.6 5 2.0 SEM years) was drawn into plastic syringes containing 
preservative-free heparin. Donors were excluded when there was a history of 
malignancy, known immunodeficiency, recent viral upper respiratory illness, or 
blood transfusion within 3 months of the evaluation. The blood was diluted v:v in 
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Ca2+- and Mg2+-free HBSS containing 0.35 g of NqHCO, per liter. The diluted 
blood was layered in 25-ml aliquots onto 9 ml of Ficoll-Hypaque gradient (Phar- 
macia Fine Chemicals, Piscataway, N.J.) and centrifuged at 4OOg for 40 min at 
room temperature. The cells at the interface were removed, washed with HBSS, 
and centrifuged at 4008 for 15 min. The cells were washed twice more, centrifuged 
at 300g for 10 min, and resuspended at a concentration of 5 x lo6 PMB/ml in 
RPMI-1640 medium (GIBCO, Grand Island, N.Y.) enriched with vitamins, 2 mM 
glutamine, penicillin (100 units/ml), streptomycin (100 pg/ml), and 10% heat- 
inactivated fetal calf serum (complete medium). 
Thymosin. Purified bovine thymosin fraction 5, generously provided by Dr. 
A. L. Goldstein (George Washington University Medical Center, Washington, 
D.C.), was prepared (9) and stored at -20°C. Concentrations ranging from 50 to 
400 pg/ml in complete medium were used. Spleen fraction 5, used as a control for 
nonspecific biological activity in the thymosin preparation, was prepared in an 
identical manner at 200 &ml. 
Suppressor and helper activity. To measure suppressor and/or helper activity 
promoted by thymosin in the presence or absence of Con A (Pharmacia Fine 
Chemicals), an MLC was used (10, 11). In the initial culture, either 0 or 20 pg of 
thymosin in a constant volume (0.1 ml) of complete medium was added to 1 ml of 
the PBM suspension in plastic tubes and incubated at 37°C for 24 hr in a 
humidified 5% CO, and air atmosphere. Parallel tubes containing 1 ml of the PBM 
suspension plus 0.1 ml of complete medium only were prepared for immediate 
use. The final volume in each tube was 1.1 ml. Following the 0 or 24-hr period of 
incubation, the PBM were resuspended and 0.55 ml of each tube was incubated in 
the presence or absence of Con A (5 &ml) for an additional 48 hr. These consti- 
tuted the 2 day and 3 day initial cultures, respectively. After incubation the control 
and Con A activated cells were treated with 50 pg/ml of mitomycin C (Sigma 
Chemical Co., St. Louis, MO) for 30 min, washed twice in 30 mM (Y- 
methylmannoside in phosphate-buffered saline to remove any residual Con A, and 
once again in complete medium. The PBM were resuspended in complete medium 
at 1 X lo6 cells/ml. 
Fresh PBM (responder cells) from a healthy donor were adjusted to 2 x lo6 
cells/ml in complete medium. For the coculture experiments, PBM from the 2 day 
or 3 day initial cultures were incubated with fresh allogeneic responder cells 
obtained from the same donor for 90 hr. The studies were performed in the wells 
of flat bottom microtiter plates (Costar, Cambridge, Mass.) to which were added 
0.05 ml of responder PBM (1 x IO5 cells), 0.1 ml of precultured PBM (1 x lo5 
cells), and 0.05 ml of complete medium containing Con A (40 Fg). In control wells 
0.05 ml of complete medium without Con A was added such that the total volume 
in each well was 0.2 ml. In some experiments spleen fraction 5 was also used in the 
same manner as thymosin. Tritiated thymidine, 2 PCi per well (New England 
Nuclear, Waltham, Mass.), was added 18 hr prior to harvesting with an automatic 
multiple sample harvester (Otto Hiller Co., Madison, Wise.). The incorporation of 
[ 3H]thymidine into cells was measured in a Beckman liquid scintillation system. 
Dose -response to thymosin. In some experiments, thymosin was added at final 
concentrations in the tubes of 5, 10, 20, and 40 pg/ml to determine the optimal 
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concentration for use in the Con A-induced suppressor cell assay. The effect of 
thymosin alone on Con A-stimulated blast formation of responder cells was evalu- 
ated by omitting Con A in the initial cultures. Culture conditions for these studies 
were identical to those described above. 
Lose of suppressor activity with preincubation. Recent studies have reported a 
loss of Con A-induced suppressor activity when PBM in the initial culture are 
incubated for 24 hr prior to activation with Con A (12- 14). The influence of a 
24-hr preincubation period on suppressor activity was determined to assess in 
vitro loss of suppressor cell activity @CA) and to evaluate the suppressor cell 
response to preincubation in the presence of thymosin. 
Calculation of helperlsuppressor activity. The data were determined as mean 
counts per minute (cpm) from quadruplicate cultures. The percentage suppression 
of responder cells by PBM from the 2 day and 3 day initial cultures not containing 
thymosin was expressed as 1 - (Acpm suppressor cellsldcpm control cells) x 100; 
where Acpm = cpm of Con A stimulated cocultures - cpm unstimulated cocul- 
tures; suppressor = Con A activated PBM from initial cultures; control = PBM 
not activated with Con A in initial cultures. The percentage suppression induced 
by treatment with thymosin or spleen fraction 5 in the 3 day initial cultures was 
calculated as 1 - (Acpm pretreated suppressor cells/Acpm control cells) x 100. 
The effect of thymosin alone, in the absence of Con A induction in the initial 
cultures, was determined as 1 - (Acpm thymosin pretreated PBM/Acpm non- 
treated PBM) x 100. A positive value reflected suppression of blast transforma- 
tion in allogeneic responder cells and a negative value indicated enhancement of 
responder cell transformation. The significance of the modulation in MLC re- 
sponse induced by Con A or thymosin was determined using Student’s paired t 
test. 
RESULTS 
Determination of Optimal Thymosin Effect 
A dose-response curve for thymosin was performed with six subjects and 
maximum suppression of allogeneic responder cells was seen at thymosin con- 
centrations of 10 and 20 PgIml. The effect of thymosin alone on the suppressive 
function of PBM was determined by omitting Con A from the initial cultures. A 
dose-response to thymosin was observed with enhancement rather than suppres- 
sion of [ 3H]thymidine incorporation by Con A-stimulated responder cells. 
Maximum enhancement was observed at concentrations of 10 and 20 pg/ml. A 
concentration of 20 &ml thymosin was therefore used for the remaining experi- 
ments. To determine if thymosin could exert a mitogenic effect, PBM from eight 
subjects were incubated for 72 hr with 0, 5, 10, and 20 pg/rnl of thymosin. No 
mitogenic effect was observed with mean cpm + SEM of 453 +: 68,482 k 64,450 
t 48, and 496 t 47, respectively. 
Con A-Induced SCA 
For the 35 subjects, the mean cpm (tSEM) in the Con A-stimulated MLC 
containing control PBM from the 2 day initial cultures was 90,390 + 5,385. Simi- 
larly the cpm in the MLC-containing control PBM from the 3 day cultures was 
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93,173 2 4,444. The percentage suppression of fresh allogeneic responder cells by 
PBM from the 2 day and 3 day initial cultures not treated with thymosin are shown 
in Table 1. There was a significant decrease in SCA when PBM in the initial 
cultures were incubated for 24 hr prior to Con A activation (3 day culture). The 
results with spleen fraction 5 in the 21 subjects evaluated were similar to that seen 
in the 3 day cultures containing untreated suppressor PBM (Table 1). 
In the 3 day initial cultures where suppressor but not control PBM were incu- 
bated with thymosin for 24 hr, significantly less suppression was observed than in 
parallel cultures containing suppressor PBM incubated in the absence of this 
modulator (Table 1). Examination of the individual responses showed that in the 
presence of thymosin, 11 of 35 subjects (9 males, 2 females; 39.8 + 4.0 years) had 
a mean absolute increase of 9.5 +- 2.4% (?SEM) in suppression over the values 
observed in parallel untreated cultures. In contrast, the remaining 24 subjects (18 
males, 6 females; 32.2 t 2.1 years) showed enhancement with a decrease in 
suppression of 13.8 + 2.7%. When the values for suppressor activity seen in the 
untreated 3 day initial cultures were stratified according to thymosin-induced 
increases or decreases in SCA observed in parallel cultures, the values obtained 
were -0.7 k 3.8% (11 subjects) and 9.8 I 2.7% (24 subjects), respectively (P < 
0.05). Although the 11 subjects tended to be older, the difference in age was not 
statistically significant. 
These experiments suggested that thymosin promoted a helper effect in a 
majority (24) of normal subjects. This supposition was confirmed in experiments 
in which Con A was omitted from the 3 day initial cultures treated with thymosin. 
Enhancement rather than suppression of Con A-stimulated blast transformation of 
responder cells was observed (-7.3 + 3.0%; 35 subjects). 
Thymosin Effect on HelpedSuppressor Activity 
In order to determine thymosin effect on Con A-induced SCA in the presence of 
a simultaneous influence on helper activity, the percentage suppression of the 
responder cells by thymosin pretreated suppressor cells was calculated using 
controls also pretreated with thymosin. Under these conditions, the percentage 
suppression did not differ significantly from the values obtained with the untreated 
suppressor cells from the 3 day initial cultures (Table 1). 
We examined the possibility that the decrease in suppression seen when the 
Con A activated PBM were pretreated with thymosin was the result of a 
thymosin-induced helper effect rather than a thymosin-promoted decrease in 
SCA. If such were the case, we could predict that the difference (A) between the 
percentage of suppression seen in initial cultures where both the suppressor and 
control cells were pretreated with thymosin and, initial cultures where the sup- 
pressor but not the control cells were incubated with thymosin would be compa- 
rable to the enhancement obtained in the MLC where PBM from the initial cul- 
tures were pretreated with thymosin, but not activated with Con A. The Pearson 
product- moment correlation test was used to ascertain coefficients of correlation 
and the related P value when comparing the predicted A in percentage suppression 
to the actual percentage suppression induced by PBM treated with thymosin but 
not activated by Con A. As shown in Table 2, there was a significant correlation 
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TABLE 2 
THYMOSIN EFFECT ON HELPER ACTIVITY IN 3 DAY INITIAL CULTURES 
(MEAN PERCENTAGE SUPPRESSION k SEM IN MLC)” 
CC) 
PBM treated with 
(A) (B) 
Suppressor and control Suppressor cells only 








































SEM I .6 
7.5 -3.3 -3.7 
5.6 -4.1 -4.5 
-21.6 -24.1 -24.7 
- 16.2 -20.1 -7.0 
8.9 - 1.4 -1.5 
17.3 24.1 22.6 
-1.3 -26.2 -34.8 
3.5 - 16.5 -20.7 
19.7 7.8 - 13.9 
6.9 - 12.3 - 15.2 
- 12.6 -26.7 - 17.8 
12.3 -0.3 -0.3 
-23.1 -40.6 -35.8 
-6.1 -20.3 -23.6 
12.3 7.9 8.3 
10.5 -6.1 -7.3 
-50.2 -61.8 -69.7 
-5.9 - 11.0 4.2 
3.9 -5.4 -6.0 
-5.5 - 14.3 - 14.2 
-4.9 -3.5 -3.5 
-7.2 -8.4 -0.8 
- 17.7 -8.5 -7.8 
5.1 - 16.7 - 13.0 
4.6 -4.2 3.8 
0.0 - 1.9 -2.0 
21.9 2.3 17.9 
15.8 -10.4 11.9 
1.5 17.0 14.7 
8.5 -4.4 -6.3 
-9.6 -13.0 3.4 
- 10.7 - 14.3 - 14.8 
6.4 -5.6 0.6 
25.3 13.5 17.2 









i( The values observed in the 35 subjects are listed. 
b After preincubation for 24 hr with thymosin, the suppressor cells were activated with Con A for 
an additional 48 hr. Suppressor and control cells were then added to the MLC. 
I PBM preincubated with thymosin for 24 hr and PBM preincubated for 24 hr in the absence of 
thymosin were incubated an additional 48 hr in the absence of Con A and added to the MLC. 
” Values represent the arithmetic difference in B from A, computed for each subject. 
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DISCUSSION 
The experiments in this study indicate that thymosin modulates a predomi- 
nantly helper effect on normal human peripheral blood T cells with no apparent 
effect on the ability of Con A to induce SCA. Thymosin-pretreated PBM activated 
with Con A increased suppression in only 11 subjects. However, these individuals 
had a significantly lower baseline suppressor activity in the untreated 3 day initial 
cultures than did the remaining 24 subjects. Thus, thymosin modulated an in- 
crease in SCA in individuals with low baseline suppressor activity and a decrease 
in SCA in subjects with higher baseline suppressor activity. This modulation of 
helper/suppressor activity parallels the balancing effect of thymosin on in vitro T 
cell counts in normal subjects as described previously (15). Thymosin appears to 
restore balance in cellular immune function rather than serving to promote a 
hyperimmune state. In a previous report utilizing the experimental systems out- 
lined in this study, thymosin significantly increased Con A-induced SCA in pa- 
tients with chronic active hepatitis who were also shown to have markedly de- 
creased baseline suppressor activity (16). Similar findings were reported in pa- 
tients with systemic lupus erythematosus (10). 
In the present study, the addition of Con A to PBM pretreated with thymosin 
did not augment the helper or suppressor effect seen with thymosin alone. While 
these observations conflict with previous reports of Con A augmenting thymosin 
effect (4, lo), it is apparent from the present series of experiments that Con A 
unmasked the equivalent suppressor activity in thymosin-pretreated PBM to that 
observed in cultures containing Con A-induced suppressor cells not treated with 
thymosin. We, like others (4), did not observe a blocking effect by thymosin to 
Con A induction of suppressor cells as previously reported (17). 
The proliferative response of human PBM appears to increase when the latter 
are incubated prior to stimulation with Con A (13, 14). It has been suggested that 
this represents a loss of short-lived suppressor cells during the preincubation 
period (13, 14,18). Recently, thymosin was shown to decrease this augmentation of 
proliferation presumably by inducing differentiation of a suppressor cell from a 
precursor population (6). In the present study, the responses observed in the 2 day 
initial cultures were monitored in the 35 subjects to assess the suppressor cell 
depletion seen in the 3 day initial cultures where PBM were incubated for 24 hr in 
the presence or absence of thymosin. In the absence of thymosin, 25 subjects (19 
males, 6 females; 36.5 + 2.3 years) showed augmentation of proliferation in the 
MLC after a 24 hr preincubation. In the remaining 10 subjects (8 males, 2 females; 
29.8 t 3.5 years), one showed no change and 9 showed an increase in suppression. 
Thymosin pretreatment further increased suppression in only 3 of 9 individuals in 
the latter group and resulted in augmentation in the remaining 6 subjects. Of the 25 
subjects showing augmentation in the absence of thymosin, pretreatment with 
thymosin decreased or abolished the proliferative response in only 4 while further 
increasing augmentation in 16. No change in proliferative response was seen in the 
remaining 5 subjects. There was no correlation between the individual responses 
to thymosin and age or sex in this group of 35 healthy subjects. Thus, we were not 
able to confirm previous reports that thymosin can induce differentiation of a 
suppressor cell from precursors in normal individuals. It is possible that there are 
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too few precursor suppressor cells in normal individuals which will differentiate 
into suppressor cells with thymosin treatment. Alternatively, PBM preincubated 
for 24 hr may not suffer a loss in SCA but instead may promote changes in the self 
regulatory dynamics of the responder cells (18, 19). It has been suggested that Con 
A does not generate suppressor cell activity in initial cultures, rather Con A- 
treated PBM may provide “less help” in the normalenhancement of responder 
cells usually observed when fresh allogeneic PBM are added (19). 
In the present study, the influence of thymosin on helper/suppressor effect in 
the presence of Con A activation may reflect a summation phenomenon. That is, 
the specific peptides in thymosin that induce help or suppression can directly 
influence regulatory status which in turn is dependent on the exact balance of T 
cell subsets, and perhaps monocytes, in the PBM suspensions. To this is added 
the known effect of Con A on regulatory T cell numbers and function (20). It is 
clear, however, that thymosin alone can promote helper function by PBM isolated 
from healthy human subjects. 
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